These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9600110)

  • 21. A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism.
    Urashima M; Hoshi Y; Sugimoto Y; Kaihara C; Matsuzaki M; Chauhan D; Ogata A; Teoh G; DeCaprio JA; Anderson KC
    Leukemia; 1996 Oct; 10(10):1576-83. PubMed ID: 8847892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW
    Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.
    Herman JG; Civin CI; Issa JP; Collector MI; Sharkis SJ; Baylin SB
    Cancer Res; 1997 Mar; 57(5):837-41. PubMed ID: 9041182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma.
    Monni O; Joensuu H; Franssila K; Klefstrom J; Alitalo K; Knuutila S
    Blood; 1997 Aug; 90(3):1168-74. PubMed ID: 9242549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of a near-triploid human B-cell lymphoma cell line with t(14;18) and a p53 gene point mutation.
    Yamaguchi H; Inokuchi K; Hanawa H; Tanosaki S; Shinozawa I; Matuoka H; Dan K
    Br J Haematol; 1999 Jun; 105(3):764-7. PubMed ID: 10354143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG; Jen J; Merlo A; Baylin SB
    Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
    Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ
    Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo acute B cell leukemia/lymphoma with t(14;18).
    Stamatoullas A; Buchonnet G; Lepretre S; Lenain P; Lenormand B; Duval C; Callat MP; Gaulard P; Bastard C; Tilly H
    Leukemia; 2000 Nov; 14(11):1960-6. PubMed ID: 11069032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc.
    Scarpa A; Moore PS; Rigaud G; Inghirami G; Montresor M; Menegazzi M; Todeschini G; Menestrina F
    Br J Haematol; 1999 Oct; 107(1):106-13. PubMed ID: 10520030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p16INK4A and p15INK4B gene deletions in primary leukemias.
    Haidar MA; Cao XB; Manshouri T; Chan LL; Glassman A; Kantarjian HM; Keating MJ; Beran MS; Albitar M
    Blood; 1995 Jul; 86(1):311-5. PubMed ID: 7795238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
    Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
    Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a human cell line (SKI-DLCL-1) with a t(1;14)(q21;q32) translocation from the ascites of a patient with diffuse large cell lymphoma.
    Goy A; Gilles F; Remache Y; Filippa D; Portlock CS; Jhanwar SC; Zelenetz AD
    Leuk Lymphoma; 2001 Jan; 40(3-4):419-23. PubMed ID: 11426565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [BCL-2 in primary central nervous system lymphomas. Immunohistochemistry and molecular biology].
    Buccoliero AM; Castiglione F; Caldarella A; Rossi Degl'Innocenti D; Taddei A; Ammannati F; Mennonna P; Taddei GL
    Pathologica; 2004 Oct; 96(5):425-9. PubMed ID: 15688978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 and p16INK4A mutations during the progression of glomus tumor.
    Güran S; Tali ET
    Pathol Oncol Res; 1999; 5(1):41-5. PubMed ID: 10079377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translocation (3;14)(q27;q11): a new variant translocation in a patient with non-Hodgkin's lymphoma of B-cell type with BCL6 rearrangement.
    Takahashi N; Miura I; Ohshima A; Utsumi S; Nimura T; Hashimoto K; Cyubachi A; Saitoh M; Enomoto K; Miki T; Hirosawa S; Miura A
    Cancer Genet Cytogenet; 1996 Aug; 90(1):49-53. PubMed ID: 8780747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.
    Malumbres M; Pérez de Castro I; Santos J; Meléndez B; Mangues R; Serrano M; Pellicer A; Fernández-Piqueras J
    Oncogene; 1997 Mar; 14(11):1361-70. PubMed ID: 9178896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
    Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
    Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.